Evidence map›Paper›PMID 39415596›Full record

ArticleHuman vaccines & immunotherapeutics2024

Epidemiological characteristics and interrupted time series analysis of mumps in Quzhou City, 2005-2023.

Canya Fu, Wenjie Xu, Wangfeng Zheng, Xiaoying Gong, Quanjun Fang, Zhiying Yin, Canjie Zheng

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Canya FuDepartment of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Wenjie XuDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
Wangfeng ZhengDepartment of Anorectal, Quzhou hospital of Traditional Chinese Medicine, Quzhou, Zhejiang, China.
Xiaoying GongDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
Quanjun FangDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
Zhiying YinDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.ORCID 0000-0002-7678-5989
Canjie ZhengDepartment of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To analyze epidemiological characteristics of mumps in different periods and explore the impact of different immunization strategies of mumps containing vaccine (MuCV) on the incidence of mumps in Quzhou. We collected reported cases of mumps in Quzhou from 2005 to 2023 for descriptive epidemiological analysis. Interrupted time series (ITS) analysis was used to assess changes in mumps incidence during the one-dose, two-dose, and the three-dose MuCV vaccination period. From 2005 to 2023, a total of 10,295 cases of mumps were reported. The average annual reported incidence rates during three period, were 57.5/100,000 (7015 cases), 14.8/100,000 (2590 cases), and 6/100,000 (690 cases), respectively. The male-to-female ratio reported cases was 1.58:1, and most cases were aged 5-9 years, accounting for 43.7%. ITS analysis showed an immediate decrease in monthly mumps incidence of 3.3951/100,000 after two-dose MuCV vaccination period (

Indexed as

Interrupted Time Series AnalysisMumpsAdolescentAdultChildChild, PreschoolChinaFemaleHumansImmunization ScheduleIncidenceInfantMaleMeasles-Mumps-Rubella VaccineMiddle AgedMumps VaccineMeasles-Mumps-Rubella VaccineMumps Vaccineepidemiological characteristicsimmunization strategyinterrupted time series analysisMumpsmumps-containing vaccine

Identifiers

PMID39415596
PMCPMC11487949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.